ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Neural Crest Gene Regulatory Networks Underlying Normal Meningeal Development and Onset of Meningioma | California Institute of Technology / Ayyappa Raja Desingu Rajan, PhD | Young Investigator Grants | 2021 | California |
Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG | Lucile Packard Children’s Hospital at Stanford University School of Medicine / Yujie Tang, PhD | Young Investigator Grants | 2014 | California |
Genetic Dissection of Cancer Drug Resistance and Toxicity Using Haploid Human Cells | Stanford University / Ramin Dubey, PhD | Young Investigator Grants | 2015 | California |
Circulating Repetitive Element RNAs as an Osteosarcoma Marker | Children’s Hospital Los Angeles / David Cobrinik, MD/PhD | Innovation Grants | 2018 | California |
Activation of Anti-Leukemia Immunity by Targeting Protein Arginine Methyltransferase | City of Hope National Medical Center / Ling Li, PhD | R Accelerated Award Grants | 2023 | California |
Role of PHF6 Mutations in Germline RUNX1 Deficiency Associated Hematopoietic Disorders | The Regents of the University of California San Francisco / Serine Avagyan, MD/PhD | RUNX1 Early Career Investigator Grants | 2021 | California |
Modeling osteosarcoma to identify novel therapeutic targets. | Stanford University / Julien Sage | Young Investigator Grants | 2006 | California |
Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma | The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D. | Reach Grants | 2014 | California |
Blockade of MYCN in neuroblastoma | University of California San Francisco / William Weiss, MD/PhD | Innovation Grants | 2011 | California |
Role of Fetal Growth in Pediatric Rhabdomyosarcoma | University of California Berkeley / Catherine Metayer, MD, PhD | Epidemiology Grants | 2013 | California |